Chemokine CCR5 antagonists incorporating a 4-aminopiperidine scaffold

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.9, 2003-09, pp. : 1469-1473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Antagonists of the Chemokine Receptor CCR5

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1299-1338

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4

By Pease James Edward Horuk Richard

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 467-483

Informa Healthcare

Access to resources Recommend Favorite

Chemokine CCR3 antagonists

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1455-1459

Informa Healthcare

Access to resources Recommend Favorite

Chemokine CCR3 antagonists

By Naya Akira Saeki Toshihiko

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 7-16

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite